Blood Journal
Leading the way in experimental and clinical research in hematology

Efficacy and safety of rituximab in B-cell post-transplant lymphoproliferative disorders: results of a prospective multicentre phase II study

This article is only available in PDF format. Please click on the PDF button to view this article.

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview